Pages that link to "Q37165703"
Jump to navigation
Jump to search
The following pages link to Current and future therapy in Alzheimer's disease. (Q37165703):
Displaying 50 items.
- Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia (Q24235058) (← links)
- Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline (Q24236736) (← links)
- eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease (Q28749125) (← links)
- Effect of Alzheimer disease genetic risk disclosure on dietary supplement use (Q28752562) (← links)
- Alzheimer's disease: clinical trials and drug development (Q33349401) (← links)
- Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model (Q33605826) (← links)
- Small Molecule Microarrays Enable the Discovery of Compounds That Bind the Alzheimer’s Aβ Peptide and Reduce its Cytotoxicity (Q33742590) (← links)
- Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans (Q33772869) (← links)
- Quantitative structure–activity relationship analysis of β-amyloid aggregation inhibitors (Q33774384) (← links)
- Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials (Q34014237) (← links)
- Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. (Q34038935) (← links)
- Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans (Q34079552) (← links)
- Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation (Q34119079) (← links)
- Neuroprotective effects of sulforaphane on cholinergic neurons in mice with Alzheimer's disease-like lesions (Q34158616) (← links)
- S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro (Q34561747) (← links)
- Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. (Q35617556) (← links)
- Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity (Q35640608) (← links)
- Alzheimer's disease and the amyloid cascade hypothesis: a critical review (Q35855587) (← links)
- Natural products as a rich source of tau-targeting drugs for Alzheimer's disease (Q36617889) (← links)
- Centella asiatica extract protects against amyloid β1-40-induced neurotoxicity in neuronal cells by activating the antioxidative defence system. (Q37346045) (← links)
- Memory loss in Alzheimer's disease: implications for development of therapeutics (Q37352057) (← links)
- Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets (Q37358683) (← links)
- Effects of combined radiofrequency field exposure on amyloid-beta-induced cytotoxicity in HT22 mouse hippocampal neurones (Q37472649) (← links)
- Membrane topology of gp41 and amyloid precursor protein: interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment. (Q37556743) (← links)
- Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease (Q37559812) (← links)
- Current therapies and new strategies for the management of Alzheimer's disease. (Q37770005) (← links)
- Potential therapeutic agents against Alzheimer’s disease from natural sources (Q37807302) (← links)
- Current perspectives on pharmacotherapy of Alzheimer's disease (Q37827489) (← links)
- Curcumin and neurodegenerative diseases: a perspective (Q38016212) (← links)
- Water Extractable Phytochemicals from Peppers (Capsicum spp.) Inhibit Acetylcholinesterase and Butyrylcholinesterase Activities and Prooxidants Induced Lipid Peroxidation in Rat Brain In Vitro (Q38284940) (← links)
- Effects of radiofrequency field exposure on glutamate-induced oxidative stress in mouse hippocampal HT22 cells (Q38744755) (← links)
- α-Mangostin decreases β-amyloid peptides production via modulation of amyloidogenic pathway. (Q38827287) (← links)
- Activation of 5-HT(2C) receptor promotes the expression of neprilysin in U251 human glioma cells (Q38934489) (← links)
- Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry (Q39302882) (← links)
- Do amyloid-lowering strategies work clinically? (Q41175983) (← links)
- Improving the quality of life in patients with Alzheimer's disease. (Q41507342) (← links)
- Natural Modulators of Amyloid-Beta Precursor Protein Processing. (Q42142611) (← links)
- Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports (Q42593353) (← links)
- Leaf and stem of Vitis amurensis and its active components protect against amyloid β protein (25–35)-induced neurotoxicity (Q42835903) (← links)
- Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors (Q42949667) (← links)
- A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection (Q42956919) (← links)
- Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development (Q43861285) (← links)
- Memantine delayed N-methyl-D-aspartate -induced convulsions in neonatal rats (Q43994143) (← links)
- Resveratrol increases cerebral glycogen synthase kinase phosphorylation as well as protein levels of drebrin and transthyretin in mice: an exploratory study (Q46688637) (← links)
- Combining in vitro and in silico approaches to find new drugs targeting the pathological proteins related to the Alzheimer's disease (Q47396500) (← links)
- Structural and functional insights into the anti-BACE1 Fab fragment that recognizes the BACE1 exosite (Q47952421) (← links)
- Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia. (Q48634809) (← links)
- S14G-Humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice (Q48847002) (← links)
- A plant cell-based system that predicts aβ42 misfolding: potential as a drug discovery tool for Alzheimer's disease (Q50491306) (← links)
- Therapeutic potential of multifunctional tacrine analogues. (Q52590407) (← links)